ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Iterum Therapeutics plc Ordinary Shares, $0.01 par value per share (ITRM)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Iterum Therapeutics plc Ordinary Shares, $0.01 par value per share
Symbol: ITRM
Shares outstanding: 28,961,082 shares
Disclosed Ownership: 1,445,158 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 17:36:23 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5%	1,445,158	0	1,445,158	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5%	1,445,158	0	1,445,158	/s/ Steven Boyd	Steven Boyd